On the involvement of calpains in the degradation of the tumor suppressor protein p53

被引:69
|
作者
Gonen, H
Shkedy, D
Barnoy, S
Kosower, NS
Ciechanover, A
机构
[1] TECHNION ISRAEL INST TECHNOL,DEPT BIOCHEM,IL-31096 HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,RAPPAPORT FAMILY INST RES MED SCI,FAC MED,IL-31096 HAIFA,ISRAEL
[3] TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL
关键词
calpain; p53; ubiquitin; proteolysis;
D O I
10.1016/S0014-5793(97)00225-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A crude fraction that contains ubiquitin-protein ligases contains also a proteolytic activity of similar to 100 kDa that cleaves p53 to several fragments. The protease does not require ATP and is inhibited in the crude extract by an endogenous similar to 250 kDa inhibitor. The proteinase can be inhibited by chelating the Ca2+ ions, by specific cysteine proteinase inhibitors and by peptide aldehyde derivatives that inhibit calpains. Purified calpain demonstrates an identical activity that can be inhibited by calpastatin, the specific protein inhibitor of the enzyme. Thus, it appears that the activity we have identified in the extract is catalyzed by calpain. The calpain in the extract degrades also N-myc, c-Fos and c-Jun, but not lysozyme. In crude extract, the calpain activity can be demonstrated only when the molar ratio of the calpain exceeds that of its native inhibitor. Recent experimental evidence implicates both the ubiquitin proteasome pathway and calpain in the degradation of the tumor suppressor, and it was proposed that the two pathways may play a role in targeting the protein under various conditions. The potential role of the two systems in this important metabolic process is discussed. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 50 条
  • [1] Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx
    Park, Sung Gyoo
    Min, Ji Young
    Chung, Chan
    Hsieh, Antony
    Jung, Guhung
    CANCER LETTERS, 2009, 282 (02) : 229 - 237
  • [2] Activation of the p53 tumor suppressor protein
    Vousden, KH
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 47 - 59
  • [3] Regulation of the p53 tumor suppressor protein
    Oren, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36031 - 36034
  • [4] Involvement of the p53 tumor-suppressor protein in the development of antinociceptive tolerance to morphine
    Tan-No, Koichi
    Shimoda, Masakazu
    Watanabe, Kenya
    Nakagawasai, Osamu
    Niijima, Fukie
    Kanno, Syu-ichi
    Ishikawa, Masaaki
    Bakalkin, Georgy
    Tadano, Takeshi
    NEUROSCIENCE LETTERS, 2009, 450 (03) : 365 - 368
  • [5] Regulation and function of the p53 tumor suppressor protein
    Ryan, KM
    Phillips, AC
    Vousden, KH
    CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (03) : 332 - 337
  • [6] Functional dissection of p53 tumor suppressor protein
    Jayaraman, L
    Freulich, E
    Prives, C
    CELL CYCLE CONTROL, 1997, 283 : 245 - 256
  • [7] THE P53 TUMOR SUPPRESSOR PROTEIN - MEETING REVIEW
    PRIVES, C
    MANFREDI, JJ
    GENES & DEVELOPMENT, 1993, 7 (04) : 529 - 534
  • [8] The tumor suppressor protein p53 and the ferroptosis network
    Kang, Rui
    Kroemer, Guido
    Tang, Daolin
    FREE RADICAL BIOLOGY AND MEDICINE, 2019, 133 : 162 - 168
  • [9] The regulation of the function of the tumor suppressor protein p53
    Szeberenyi, J
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2003, 31 (06) : 435 - 436
  • [10] Interaction of metallothionein with tumor suppressor p53 protein
    Ostrakhovitch, EA
    Olsson, PE
    Jiang, S
    Cherian, MG
    FEBS LETTERS, 2006, 580 (05): : 1235 - 1238